Daxor Gross Profit 2010-2011 | DXR

Daxor gross profit from 2010 to 2011. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Daxor Annual Gross Profit
(Millions of US $)
2011 $1
2010 $1
2009 $1
Daxor Quarterly Gross Profit
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.044B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.391B 11.73
Quest Diagnostics (DGX) United States $16.058B 16.47
DaVita (DVA) United States $12.497B 15.52
Encompass Health (EHC) United States $9.126B 23.36
Chemed (CHE) United States $8.190B 25.03
Elanco Animal Health (ELAN) United States $6.335B 16.44
Option Care Health (OPCH) United States $5.388B 20.40
RadNet (RDNT) United States $4.578B 95.34
Amedisys (AMED) United States $3.194B 22.89
Astrana Health (ASTH) United States $2.939B 39.76
Addus HomeCare (ADUS) United States $2.192B 28.36
LifeStance Health (LFST) United States $2.118B 0.00
U.S Physical Therapy (USPH) United States $1.462B 39.11
Pennant (PNTG) United States $0.878B 46.37
Aveanna Healthcare Holdings (AVAH) United States $0.818B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00